Griseofulvin Tablets, USP are indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy, hair and nails.

Griseofulvin Tablets, USP (microsize)
  • Compare to
    Grifulvin V®*
Inactive Ingredients

Corn starch, povidone, polyethylene glycol 400, polyethylene glycol 8000, lactose monohydrate, crospovidone, silicon dioxide and magnesium stearate.

*Grifulvin V® is a registered trademark of Valeant International SRL.

Griseofulvin Tablets, USP (microsize) (500 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    500 mg
  • NDC Code
    42794-0012-08
Griseofulvin Tablets, USP (microsize) (500 mg)

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.